Name: Zimmer Biomet Holdings Inc Financial Statements
Creator: Quarter Results

Income statement quarterly history for Zimmer Biomet Holdings Inc (ZBH).
Income Statement (Quarterly)	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Revenue	1,909,100,000	2,023,200,000	1,824,200,000	1,942,000,000
Cost of Revenue	549,800,000	586,700,000	538,600,000	553,600,000
Gross Profit	1,359,300,000	1,436,500,000	1,285,600,000	1,388,400,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	758,800,000	746,900,000	709,700,000	737,100,000
Operating Expenses	1,067,000,000	1,047,500,000	1,006,100,000	1,037,100,000
Operating Income	292,300,000	389,000,000	279,500,000	351,300,000
Interest Expense	66,200,000	61,900,000	54,300,000	51,100,000
Income Before Tax	229,000,000	289,000,000	230,300,000	302,200,000
Income Tax Expense	46,500,000	48,900,000	-18,900,000	59,100,000
Net Income	182,000,000	239,500,000	249,100,000	242,800,000
Per Share
EPS	0.92	1.20	1.23	1.18
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Zimmer Biomet Holdings Inc (ZBH).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	8,231,500,000	7,678,600,000	7,394,200,000	6,939,900,000	7,836,200,000
Cost of Revenue	3,159,600,000	2,191,200,000	2,083,800,000	2,019,500,000	2,341,000,000
Gross Profit	5,071,900,000	5,487,400,000	5,310,400,000	4,920,400,000	5,495,200,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	3,251,200,000	2,929,800,000	2,838,900,000	2,761,700,000	3,323,900,000
Operating Expenses	3,709,700,000	4,201,700,000	4,032,700,000	3,728,300,000	4,489,900,000
Operating Income	1,362,200,000	1,285,700,000	1,277,700,000	1,064,100,000	780,100,000
Interest Expense	292,800,000	218,000,000	201,200,000	164,800,000	208,400,000
Income Before Tax	830,800,000	1,036,600,000	1,067,300,000	403,500,000	418,400,000
Income Tax Expense	125,700,000	131,400,000	42,200,000	112,300,000	16,300,000
Net Income	705,200,000	903,800,000	1,024,000,000	231,400,000	401,600,000
Per Share
EPS	3.56	4.45	4.91	1.39	1.93
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Zimmer Biomet Holdings Inc (ZBH).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	591,900,000	525,500,000	415,800,000	375,700,000
Short Term Investments	0	0	0	6,800,000
Net Receivables	1,704,400,000	1,480,700,000	1,442,400,000	1,381,500,000
Inventory	2,286,400,000	2,235,300,000	2,385,200,000	2,147,200,000
Total Current Assets	5,119,900,000	4,671,500,000	4,609,500,000	4,427,300,000
Property Plant Equipment	2,207,100,000	2,048,800,000	2,264,200,000	1,872,500,000
Goodwill and Intangibles	14,664,400,000	13,549,500,000	13,674,900,000	13,644,000,000
Total Assets	23,091,700,000	21,365,300,000	21,496,900,000	21,066,000,000
Liabilities
Account Payables	0	194,600,000	410,600,000	354,100,000
Short Term Debt	587,100,000	863,000,000	986,200,000	544,300,000
Total Current Liabilities	2,583,700,000	2,450,900,000	2,857,400,000	2,358,200,000
Long Term Debt	6,932,000,000	5,341,600,000	5,042,300,000	5,152,200,000
Total Liabilities	10,385,900,000	8,889,100,000	9,008,700,000	9,039,000,000
Shareholders Equity
Retained Earnings	0	11,095,300,000	10,384,500,000	9,559,300,000
Total Shareholders Equity	12,705,800,000	12,468,100,000	12,480,500,000	12,021,300,000

Balance sheet annual history for Zimmer Biomet Holdings Inc (ZBH).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	591,900,000	525,500,000	415,800,000	375,700,000	478,500,000
Short Term Investments	0	0	0	6,800,000	0
Net Receivables	1,704,400,000	1,480,700,000	1,442,400,000	1,381,500,000	1,404,900,000
Inventory	2,286,400,000	2,235,300,000	2,385,200,000	2,147,200,000	2,394,500,000
Total Current Assets	5,119,900,000	4,671,500,000	4,609,500,000	4,427,300,000	4,885,000,000
Property Plant Equipment	2,207,100,000	2,048,800,000	2,264,200,000	1,872,500,000	2,016,500,000
Goodwill and Intangibles	14,664,400,000	13,549,500,000	13,674,900,000	13,644,000,000	15,492,000,000
Total Assets	23,091,700,000	21,365,300,000	21,496,900,000	21,066,000,000	23,456,400,000
Liabilities
Account Payables	0	194,600,000	410,600,000	354,100,000	351,200,000
Short Term Debt	587,100,000	863,000,000	986,200,000	544,300,000	1,605,100,000
Total Current Liabilities	2,583,700,000	2,450,900,000	2,857,400,000	2,358,200,000	3,467,900,000
Long Term Debt	6,932,000,000	5,341,600,000	5,042,300,000	5,152,200,000	5,474,200,000
Total Liabilities	10,385,900,000	8,889,100,000	9,008,700,000	9,039,000,000	10,790,000,000
Shareholders Equity
Retained Earnings	0	11,095,300,000	10,384,500,000	9,559,300,000	10,292,200,000
Total Shareholders Equity	12,705,800,000	12,468,100,000	12,480,500,000	12,021,300,000	12,660,700,000

Cash flow quarterly history for Zimmer Biomet Holdings Inc (ZBH).
Cash Flow Statement (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Operating Activities
Net Income	705,200,000	905,200,000	1,024,000,000	291,200,000
Depreciation & Amortization	1,093,800,000	996,300,000	951,700,000	926,400,000
Stock Based Compensation	0	101,000,000	99,800,000	105,000,000
Change in Working Capital	-104,900,000	-455,400,000	-396,200,000	-311,400,000
Operating Cash Flow	1,697,000,000	1,499,400,000	1,581,600,000	1,284,700,000
Investing Activities
Capital Expenditure	-224,500,000	-356,800,000	-689,200,000	-187,900,000
Investments	-276,900,000	-203,800,000	-689,200,000	-187,900,000
Investing Cash Flow	-1,975,700,000	-888,100,000	-778,900,000	-529,200,000
Financing Activities
Debt Repayment	1,006,400,000	536,300,000	-48,800,000	-1,738,700,000
Common Stock Issued/Repurchased	-447,300,000	-868,000,000	-591,100,000	-48,300,000
Dividends Paid	-190,300,000	-196,000,000	-200,900,000	-201,200,000
Financing Cash Flow	326,000,000	-484,500,000	-763,500,000	-843,800,000
Summary
Free Cash Flow	1,472,500,000	1,142,600,000	892,400,000	1,096,800,000
Net Change in Cash	66,400,000	109,700,000	40,100,000	-102,800,000

Cash flow annual history for Zimmer Biomet Holdings Inc (ZBH).
Cash Flow Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	705,200,000	905,200,000	1,024,000,000	291,200,000	402,100,000
Depreciation & Amortization	1,093,800,000	996,300,000	951,700,000	926,400,000	1,067,400,000
Stock Based Compensation	0	101,000,000	99,800,000	105,000,000	85,300,000
Change in Working Capital	-104,900,000	-455,400,000	-396,200,000	-311,400,000	-87,300,000
Operating Cash Flow	1,697,000,000	1,499,400,000	1,581,600,000	1,284,700,000	1,499,200,000
Investing Activities
Capital Expenditure	-224,500,000	-356,800,000	-689,200,000	-187,900,000	-180,400,000
Investments	-276,900,000	-203,800,000	-689,200,000	-187,900,000	-172,000,000
Investing Cash Flow	-1,975,700,000	-888,100,000	-778,900,000	-529,200,000	-503,600,000
Financing Activities
Debt Repayment	1,006,400,000	536,300,000	-48,800,000	-1,738,700,000	-2,654,800,000
Common Stock Issued/Repurchased	-447,300,000	-868,000,000	-591,100,000	-48,300,000	0
Dividends Paid	-190,300,000	-196,000,000	-200,900,000	-201,200,000	-200,100,000
Financing Cash Flow	326,000,000	-484,500,000	-763,500,000	-843,800,000	-1,306,000,000
Summary
Free Cash Flow	1,472,500,000	1,142,600,000	892,400,000	1,096,800,000	1,318,800,000
Net Change in Cash	66,400,000	109,700,000	40,100,000	-102,800,000	-323,600,000

Zimmer Biomet Holdings Inc (ZBH)